NIH Reporter #5K08AI177743-02

NIAID Grant for Research on Early-Life CD8 T Cell Responses and PI3K/mTOR Pathways

This opportunity is a research grant solicitation from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), focused on early-life CD8 T cell responses. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Purpose: - Grant supports research on PI3K/mTOR signaling pathways in early-life CD8 T cell responses - Goal is to identify therapeutic targets to improve immune responses in neonates and children with severe viral infections - OEMs and Vendors: - No specific OEMs or vendors are mentioned - Products/Services Requested: - No products, part numbers, or quantities specified - No specific services or line items listed - Unique/Notable Requirements: - Research must focus on targetable pathways in immune response - Associated with Yale University - No unique license or classification requirements specified - No attachments or detailed bid schedule provided

Description

This NIH grant opportunity supports research on early-life CD8 T cell responses, focusing on PI3K/mTOR signaling pathways. The project aims to identify therapeutic targets to improve immune responses in neonates and children with severe viral infections. The award is part of the PA-20-203 funding opportunity, with a project period from August 2024 to July 2029. The research is conducted at Yale University under the National Institute of Allergy and Infectious Diseases (NIAID), NIH.

View original listing